Welcome To The Prostate Cancer Research Institute
The mission of the PCRI is to help men know their options. A new diagnosis of prostate cancer is emotionally shocking. Men are surprised by a new diagnosis because prostate cancer symptoms almost never occur. This is why PSA screening has been so revolutionary. Until the early 1990s when PSA screening started, most men were being diagnosed in an advanced prostate cancer stage.
This website provides in-depth information about all stages of prostate cancer. A number of important questions need to be answered: First, can prostate cancer be prevented? Are there specific supplements that are helpful or hurtful? Can diet and exercise prevent prostate cancer? Second, what is the best method for doing prostate cancer screening? Should the PSA blood test be used? If so, at what age should PSA screening begin? Should older men take the PSA blood test?Read More
Men with newly diagnosed prostate cancer face innumerable questions. For example, men with newly diagnosed prostate cancer have not have heard all the pros and cons of common prostate cancer treatments such as prostatectomy, active surveillance and hormone treatment. While active surveillance is gaining acceptance for men with low risk prostate cancer many men don’t realized that for men with intermediate risk prostate cancer there are at least fifteen prostate cancer treatments to consider. Men with newly diagnosed high risk prostate cancer have well over a half-dozen different prostate cancer treatments to consider. Combination treatment with hormone treatment combined with either prostatectomy or radiation therapy is usually recommended in men with high risk prostate cancer.
Prostate cancer is very different from other cancers. A PSA relapse after treatment with prostatectomy or radiation does not have the same frightening aspect associated with cancer recurrence of other common cancer. Prostate cancer recurrence is detected at such an early stage most common body and bone scans are totally clear. The early initiation of hormone therapy on average will keep men with a PSA relapse in remission for over 10 years.
Treatment of advanced prostate cancer is changing quickly. The FDA has approved five new prostate cancer treatments in the last two years. For men with advanced prostate cancer this website provides detailed information about the effectiveness and side effects of new pharmaceuticals such as Provenge, Zytiga, Xtandi, Xgeva, Xofigo and Jevtana.
The PCRI is happy to serve the prostate cancer community by providing a website with extensive up to date information. Contact our trained helpline personal for assistance in utilizing this rich resource.
Annual Conference: Every September, we bring world-renowned authorities together to teach you your options. We even let you corner them in workshops! If you missed it, signup for next year and order this year’s DVD.
Helpline: Our Helpline facilitators are here to personally help you understand your options and choose wisely. Call the Helpline at: 1-800-641-7274.
PCRI Insights Magazine: Our quarterly newsletter shares state-of-the-art prostate cancer fighting information. To receive it by email insert your email address in the form thats in the side bar on the right hand side. To have it sent by UPS please contact us by email with your name and shipping address at firstname.lastname@example.org.
PCRI Weekly News: This e-mail newsletter keeps you going with practical information to prevent, detect, and treat prostate cancer.
Multimedia Teaching Aides: For our partners, we have collected articles, PowerPoint slides and educational videos from our top-level faculty to teach you.
PCRI Guidance (PCRI Papers): We have collected important summary articles to help you prevent, diagnose, and treat even advanced prostate cancer.
Shades of Blue: We teach you a simple method of classifying your prostate cancer stage. This helps you understand and communicate your needs and expectations to your physician.
Blue Community: Join our online forums to share your story and find support that is relevant to where you are at in the above shades of blue.
Clinical Trials: The PCRI Helpline and website will help you research clinical trials. Learn about the expanded access program that makes new drugs available to eligible patients before FDA approval.